PRESS RELEASES

Osteoboost Joins AgeTech Collaborative™ from AARP Accelerator Program

One of the biggest challenges of aging is the loss of bone density, which too often leads to osteoporosis and serious fractures that significantly impact quality of life.  Our mission with Osteoboost is to slow the process of bone loss and preserve bone density and strength, helping people live stronger,…
Read more

Two women walking wearing Osteoboost belts overlaid by two smartphones showing the Wellen exercise app

Bone Health Technologies Acquires Wellen

Bone Health Technologies takes a pivotal step toward a future of comprehensive one-stop bone health care for patients everywhere REDWOOD CITY, Calif. (July 25, 2024) – Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health and reduce fractures, today announced the company…
Read more

Bone Health Technologies Granted Fifth U.S. Patent for Low Bone Density Treatment Osteoboost, Adds Two Key Executives

REDWOOD CITY, CA (July 2, 2024) – Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia. The patent, US…
Read more

Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care

BHT closes oversubscribed financing round, adds new investors to revolutionize low bone density treatments Redwood City, CA – March 4, 2024 – Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from…
Read more

Bone Health Technologies Announces FDA Clearance of Osteoboost, the First Prescription Medical Device to Treat Low Bone Density

Redwood City, CA – January 18, 2024 – Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density).  Osteoboost is a wearable belt device, worn on the…
Read more

Bone Health Technologies Awarded New Patent for Wearable Treatment for Osteopenia and Osteoporosis in Post-Menopausal Women 

First Device to Demonstrate Bone Strength Benefit in Clinical Trial REDWOOD CITY, CA (DEC, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, has been granted its fourth patent to further its commercialization of the Osteoboost device. Osteoboost has been shown in clinical trials…
Read more

Bone Health Technologies to Present Clinical Data at ASBMR 2023 from Pivotal Trial of Wearable Treatment for Osteopenia in Post-Menopausal Women

Osteoboost Reduced the Loss of Vertebral Bone Strength by 83% in One Year for Per Protocol Participants Vancouver, BC, Canada (October 13, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, is presenting top-line results from its pivotal trial for the Osteoboost at ASBMR…
Read more